Effectiveness of Apneic Oxygenation during Intubation: A systemic review and meta-analysis by Silva et al 2017
- Population: ED and ICU patients; both RCT and observational studies included.
- Not OR or outside hospital patients
- Intervention:
- Some received High Flow at 60L/min -Transnasal Humidified rapid insufflation ventilator exchange (THRIVE technique). Some PEEP.
- Some received Nasal cannula at 15L/Min (Nasal Oxygen during efforts securing a tube- NO DESAT). No PEEP.
- Comparison; no apneic ox although 3 studies did not have comparison groups
- Outcome
- Lowest SpO2 peri-intubation; usually measured from time of drug injection until mechanical ventilation but not available for all studies
- In 6 studies, the lowest SpO2 was higher for the ApOx group than for standard ox (difference of 2.21%; 95% CI 0.81-3.61)
- Crosses 1 but scale set so zero is the dividing line rather than the typical 1
- In 6 studies, the lowest SpO2 was higher for the ApOx group than for standard ox (difference of 2.21%; 95% CI 0.81-3.61)
- First Pass success
- In 6 studies, ApOx had increased first pass success OR 1.59; 95% CI 1.04-2.44)
- Incidence of hypoxemia less than 93%
- OR 0.66; 95%CI 0.52-0.84
- Severe hypoxemia <80% - not significant
- Life threatening hypoxemia <70% - not significant
- ICU length of stay – only 368 pts but statistically significant with mean decrease in length of stay of 2.88 days in ap ox group
- Mortality- not significant
- Lowest SpO2 peri-intubation; usually measured from time of drug injection until mechanical ventilation but not available for all studies
- 14 studies for qualitative review
- 8 studies for quantitative review (out of the 14)
- 1837 patients. 932 pts had apneic oxygenation, 855 did not
- Apneic Ox had increased peri-intubation ox saturation difference of 2.21%; 95% CI 0.81-3.61
- Decreased rates of hypoxemia OR 0.66; 95%CI 0.52-0.84
- Not significant beneficial for cases of severe hypoxemia OR 0.86; 95% CI 0.47-1.57
- Increased first pass success OR 1.59; 95% CI 1.04-2.44
- Rationale: apneic oxygenation revolves around physiologic capacity of continuous oxygen capture by alveoli through passive process without providing ventilation
- Used several tools to limit bias
- Only had a moderate kappa between 2 coders over which studies to include
- Limitations:
- moderate to low level of certainty in estimates
- different methods of Ap Ox (HF vs NC)
- Does higher rates of first pass success also mean less oxygen desaturation, affecting that result?
- When only using low risk of bias studies, none of the outcomes showed improvement with ApOx but the sample sizes were small/not enough power.
Emergency Department use of Apneic Oxygenation vs usual care during rapid sequence intubation: a randomized controlled trial (The ENDAO Trial) by Caputo et al 2016
- Population: 206 ED adult patients requiring intubation but excluding cardiac/traumatic arrest or people who didn’t get pre-oxygenation via NRB/bipap/bvm or awake intubation
- Intervention: Apneic oxygenation received nasal cannula oxygen and ETCO2 NC both at flush flow rates of >15L/min
- Comparison: Usual Care (just pre-oxygenation)
- Primary Outcome: Avg lowest O2 saturation during apnea period or in 2 minutes following intubation
- Looked for a difference of 5% (Cohen’s D statistic of 0.4 for moderate effect size)
- No difference between the 2 groups 92% Oxygen saturation; 95% CI 91-93 in AO vs 93, 95% CI 92-94in UC, p=0.11)
- Secondary:
- Increased first pass success? Everyone except 22 patients. Even these didn’t desat below 90 however 15 of them weren’t intubated for pulmonary reasons.
- Decreased rates of desaturation below 90? 80? No significant difference
- Time to desaturation? No significant difference
- Mortality? No significant difference
- Secondary:
- Pre-oxygenation is providing supplemental O2 w/ goal of 100% FiO2 for at least 3 minutes prior to RSI to increase amount of O2 in the functional residual capacity of the lungs
- Apneic oxygenation- leave the NC on after RSI and while visualizing the vocal corts/placing the ETTube.
- FELLOW trial showed no difference in desaturation rates between ApOx and usual practice in ICU patients; other studies refute these results
- Pre-oxygenation technique at discretion of attending (BVM vs Bipap vs NRB)
- Video vs DL and RSI meds at attending discretion
- Apnea time from first look (not Med push) to EtCO2 confirmation (not being placed on the vent)- this is a shorter time than the meta-analysis.
- Used this because you KNOW the patient is paralyzed/apneic
- Subgroup w/ prolonged apnea time of 130+seconds did not desaturate to less than 90%
- Limitations: real time data collection may underestimate AE and time to intubation. Also single center study in academic center.
- Similar results as FELLOW study but different in that everyone received pre-oxygenation.
- Perhaps Ap Ox would be useful in those who have not been pre-oxygenated? E.g. crash intubations
Looking at both of these and how the conflict, consider the following: Does it apply to your population? Do you have the resources? Any harms? Any benefits that you've seen?